Governor Glenn Youngkin announced Monday that AstraZeneca selected Virginia for a multi-billion-dollar manufacturing center ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the United States by 2030, it ...

Analysts questioned whether the complete response letter Replimune received was evidence of changing approval standards at ...

Dr. George Tidmarsh, a Stanford pediatrics adjunct professor and former pharmaceutical executive, is FDA Commissioner Marty Makary’s pick to be the nation’s top drug regulator.

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life ...

Replimune stock (ticker: REPL) cratered on Tuesday after the biotech said the U.S. Food and Drug Administration rejected an ...

The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.

With ₹700 crore in budgetary support, seven CoEs have been established at the National Institutes of Pharmaceutical Education ...

The Danaher Business System focuses on continuous improvement, including the acceleration of core growth and margin expansion through marketing initiatives and innovation, which appears positive for ...

The investment is highlighted by a state-of-the-art API facility in Virginia and expansions across multiple states.

With certain drug shortages persisting across the U.S., pharmacy leaders are adopting more coordinated strategies to manage supply disruptions. These include expanding on-hand inventory for critical ...

The deal sees Ampersand Capital Partners acquire the company that has manufacturing locations in both South Carolina and the ...